Global Oncology Informatics Market 2020-2030

Bonafide Trust 26-08-2020 170 Pages Figures : 79 Tables : 87
Region : Global Category : Lifescience Biotechnology

Request new version

Request for updated version of the report at the same price

Order Now

Report Description
Table of Contents
List of Figure Tables

Global oncology informatics market will reach $8,602.3 million by 2030, growing by 6.1% annually over 2020-2030 driven by the surge of cancer incidence, increasing cost of cancer treatment, and growing trend of reducing medical errors and readmission rates. Highlighted with 87 tables and 79 figures, this 170-page report “Global Oncology Informatics Market 2020-2030 by Product Type (EHR, PHM, CDSS, DDDI), Cancer Type, Application (Medical, Surgical, Radiation), End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global oncology informatics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global oncology informatics market in every aspect of the classification from perspectives of Product Type, Cancer Type, Application, End User, and Region. Based on Product Type, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Electronic Health Records (EHRs) • Population Health Management (PHM) • Clinical Decision Support System (CDSS) • Drug Discovery and Development Informatics (DDDI) • Data Analytics • Image Analytics • Other Product Types Based on Cancer Type, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Colorectal Cancer • Breast Cancer • Prostate Cancer • Cervical Cancer • Other Cancers Based on Application, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Medical Application • Surgical Application • Radiation Application Based on End User, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Pharmaceutical Companies • Life Science Companies • Contract Research Organizations (CROs) • Academic Institutes and Research Centers • Other End Users Geographically, the following regions together with the listed national/local markets are fully investigated: • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka) • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania) • North America (U.S., Canada, and Mexico) • South America (Brazil, Chile, Argentina, Rest of South America) • RoW (Saudi Arabia, UAE, South Africa) For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Product Type, Cancer Type, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in global oncology informatics market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions. Key Players (this may not be a complete list and extra companies can be added upon request): Cerner Corporation Change Healthcare Elekta AB F.Hoffmann-La Roche Ltd. Hologic Inc. IBM Corporation Inspirata Inc. Koninklijke Philips N.V. Laboratory Corporation of America Holdings McKesson Corporation MIM Software, Inc. Oncology Analytics, Inc PerkinElmer, Inc. RELX Group Sirenas, LLC UnitedHealth Group, Inc Varian Medical Systems, Inc (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 8

1.1 Industry Definition and Research Scope 8

1.1.1 Industry Definition 8

1.1.2 Research Scope 9

1.2 Research Methodology 12

1.2.1 Overview of Market Research Methodology 12

1.2.2 Market Assumption 13

1.2.3 Secondary Data 13

1.2.4 Primary Data 13

1.2.5 Data Filtration and Model Design 15

1.2.6 Market Size/Share Estimation 16

1.2.7 Research Limitations 17

1.3 Executive Summary 18

2 Market Overview and Dynamics 21

2.1 Market Size and Forecast 21

2.1.1 Impact of COVID-19 on the Market 22

2.2 Major Growth Drivers 24

2.3 Market Restraints and Challenges 27

2.4 Emerging Opportunities and Market Trends 30

2.5 Porter’s Fiver Forces Analysis 34

3 Segmentation of Global Market by Product Type 38

3.1 Market Overview by Product Type 38

3.2 Electronic Health Records (EHRs) 40

3.3 Population Health Management (PHM) 42

3.4 Clinical Decision Support System (CDSS) 44

3.5 Drug Discovery and Development Informatics (DDDI) 46

3.6 Data Analytics 48

3.7 Image Analytics 49

3.8 Other Product Types 50

4 Segmentation of Global Market by Cancer Type 51

4.1 Market Overview by Cancer Type 51

4.2 Colorectal Cancer 53

4.3 Breast Cancer 54

4.4 Prostate Cancer 55

4.5 Cervical Cancer 56

5 Segmentation of Global Market by Application 57

5.1 Market Overview by Application 57

5.2 Medical Application 59

5.3 Surgical Application 60

5.4 Radiation Application 61

6 Segmentation of Global Market by End User 63

6.1 Market Overview by End User 63

6.2 Pharmaceutical Companies 65

6.3 Life Science Companies 66

6.4 Contract Research Organizations (CROs) 67

6.5 Academic Institutes and Research Centers 68

6.6 Other End Users 69

7 Segmentation of Global Market by Region 70

7.1 Geographic Market Overview 2019-2030 70

7.2 North America Market 2019-2030 by Country 74

7.2.1 Overview of North America Market 74

7.2.2 U.S. 78

7.2.3 Canada 82

7.2.4 Mexico 84

7.3 European Market 2019-2030 by Country 86

7.3.1 Overview of European Market 86

7.3.2 Germany 90

7.3.3 UK 92

7.3.4 France 94

7.3.5 Spain 96

7.3.6 Italy 98

7.3.7 Russia 100

7.3.8 Rest of European Market 102

7.4 Asia-Pacific Market 2019-2030 by Country 104

7.4.1 Overview of Asia-Pacific Market 104

7.4.2 Japan 108

7.4.3 China 111

7.4.4 Australia 113

7.4.5 India 115

7.4.6 South Korea 117

7.4.7 Rest of APAC Region 119

7.5 South America Market 2019-2030 by Country 121

7.5.1 Argentina 124

7.5.2 Brazil 126

7.5.3 Chile 128

7.5.4 Rest of South America Market 130

7.6 MEA Market 2019-2030 by Country 131

7.6.1 UAE 134

7.6.2 Saudi Arabia 136

7.6.3 South Africa 138

7.6.4 Other National Markets 140

8 Competitive Landscape 141

8.1 Overview of Key Vendors 141

8.2 New Product Launch, Partnership, Investment, and M&A 145

8.3 Company Profiles 146

Cerner Corporation 146

Change Healthcare 148

Elekta AB 149

F.Hoffmann-La Roche Ltd. 150

Hologic Inc. 151

IBM Corporation 152

Inspirata Inc. 153

Koninklijke Philips N.V. 154

Laboratory Corporation of America Holdings 155

McKesson Corporation 156

MIM Software, Inc. 157

Oncology Analytics, Inc 158

PerkinElmer, Inc. 159

RELX Group 160

Sirenas, LLC 161

UnitedHealth Group, Inc 162

Varian Medical Systems, Inc 163

9 Investing in Global Market: Risk Assessment and Management 164

9.1 Risk Evaluation of Global Market 164

9.2 Critical Success Factors (CSFs) 167

Related Reports and Products 170

Figure 1. Research Method Flow Chart 12
Figure 2. Breakdown of Primary Research 14
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 16
Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 18
Figure 5. Global Oncology Informatics Market, 2019-2030, $ mn 21
Figure 6. Impact of COVID-19 on Business 22
Figure 7. Primary Drivers and Impact Factors of Global Oncology Informatics Market 24
Figure 8. Primary Restraints and Impact Factors of Global Oncology Informatics Market 27
Figure 9. Investment Opportunity Analysis 31
Figure 10. Porter’s Fiver Forces Analysis of Global Oncology Informatics Market 34
Figure 11. Breakdown of Global Oncology Informatics Market by Product Type, 2019-2030, % of Revenue 39
Figure 12. Global Addressable Market Cap in 2020-2030 by Product Type, Value ($ mn) and Share (%) 39
Figure 13. Global Oncology Informatics Market: Electronic Health Records (EHRs), 2019-2030, $ mn 40
Figure 14. Global Oncology Informatics Market: Population Health Management (PHM), 2019-2030, $ mn 42
Figure 15. Global Oncology Informatics Market: Clinical Decision Support System (CDSS), 2019-2030, $ mn 44
Figure 16. Global Oncology Informatics Market: Drug Discovery and Development Informatics (DDDI), 2019-2030, $ mn 46
Figure 17. Global Oncology Informatics Market: Data Analytics, 2019-2030, $ mn 48
Figure 18. Global Oncology Informatics Market: Image Analytics, 2019-2030, $ mn 49
Figure 19. Global Oncology Informatics Market: Other Product Types, 2019-2030, $ mn 50
Figure 20. Breakdown of Global Oncology Informatics Market by Cancer Type, 2019-2030, % of Sales Revenue 51
Figure 21. Global Addressable Market Cap in 2020-2030 by Cancer Type, Value ($ mn) and Share (%) 52
Figure 22. Global Oncology Informatics Market: Colorectal Cancer, 2019-2030, $ mn 53
Figure 23. Global Oncology Informatics Market: Breast Cancer, 2019-2030, $ mn 54
Figure 24. Global Oncology Informatics Market: Prostate Cancer, 2019-2030, $ mn 55
Figure 25. Global Oncology Informatics Market: Cervical Cancer, 2019-2030, $ mn 56
Figure 26. Breakdown of Global Oncology Informatics Market by Application, 2019-2030, % of Sales Revenue 57
Figure 27. Global Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%) 58
Figure 28. Global Oncology Informatics Market: Medical Application, 2019-2030, $ mn 59
Figure 29. Global Oncology Informatics Market: Surgical Application, 2019-2030, $ mn 60
Figure 30. Global Oncology Informatics Market: Radiation Application, 2019-2030, $ mn 61
Figure 31. Breakdown of Global Oncology Informatics Market by End User, 2019-2030, % of Revenue 63
Figure 32. Global Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%) 64
Figure 33. Global Oncology Informatics Market: Pharmaceutical Companies, 2019-2030, $ mn 65
Figure 34. Global Oncology Informatics Market: Life Science Companies, 2019-2030, $ mn 66
Figure 35. Global Oncology Informatics Market: Contract Research Organizations (CROs), 2019-2030, $ mn 67
Figure 36. Global Oncology Informatics Market: Academic Institutes and Research Centers, 2019-2030, $ mn 68
Figure 37. Global Oncology Informatics Market: Other End Users, 2019-2030, $ mn 69
Figure 38. Global Market Snapshot by Region 70
Figure 39. Geographic Spread of Worldwide Oncology Informatics Market, 2019-2030, % of Sales Revenue 71
Figure 40. Global Addressable Market Cap in 2020-2030 by Region, Value ($ mn) and Share (%) 72
Figure 41. North American Oncology Informatics Market, 2019-2030, $ mn 75
Figure 42. Breakdown of North America Oncology Informatics Market by Country, 2019 and 2030, % of Revenue 76
Figure 43. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 77
Figure 44. U.S. Oncology Informatics Market, 2019-2030, $ mn 79
Figure 45. Canada Oncology Informatics Market, 2019-2030, $ mn 82
Figure 46. Oncology Informatics Market in Mexico, 2015-2030, $ mn 84
Figure 47. European Oncology Informatics Market, 2019-2030, $ mn 87
Figure 48. Breakdown of European Oncology Informatics Market by Country, 2019 and 2030, % of Revenue 88
Figure 49. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 89
Figure 50. Oncology Informatics Market in Germany, 2019-2030, $ mn 90
Figure 51. Oncology Informatics Market in UK, 2019-2030, $ mn 92
Figure 52. Oncology Informatics Market in France, 2019-2030, $ mn 94
Figure 53. Oncology Informatics Market in Spain, 2019-2030, $ mn 96
Figure 54. Oncology Informatics Market in Italy, 2019-2030, $ mn 98
Figure 55. Oncology Informatics Market in Russia, 2019-2030, $ mn 100
Figure 56. Oncology Informatics Market in Rest of Europe, 2019-2030, $ mn 102
Figure 57. Asia-Pacific Oncology Informatics Market, 2019-2030, $ mn 105
Figure 58. Breakdown of APAC Oncology Informatics Market by Country, 2019 and 2030, % of Revenue 105
Figure 59. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 107
Figure 60. Oncology Informatics Market in Japan, 2019-2030, $ mn 109
Figure 61. Oncology Informatics Market in China, 2019-2030, $ mn 111
Figure 62. Oncology Informatics Market in Australia, 2019-2030, $ mn 113
Figure 63. Oncology Informatics Market in India, 2019-2030, $ mn 115
Figure 64. Oncology Informatics Market in South Korea, 2019-2030, $ mn 117
Figure 65. Oncology Informatics Market in Rest of APAC, 2019-2030, $ mn 119
Figure 66. South America Oncology Informatics Market, 2019-2030, $ mn 122
Figure 67. Breakdown of South America Oncology Informatics Market by Country, 2019 and 2030, % of Revenue 122
Figure 68. Contribution to South America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 123
Figure 69. Oncology Informatics Market in Argentina, 2019-2030, $ mn 124
Figure 70. Oncology Informatics Market in Brazil, 2019-2030, $ mn 126
Figure 71. Oncology Informatics Market in Chile, 2019-2030, $ mn 128
Figure 72. Oncology Informatics Market in Rest of South America, 2019-2030, $ mn 130
Figure 73. Oncology Informatics Market in Middle East and Africa (MEA), 2019-2030, $ mn 132
Figure 74. Breakdown of MEA Oncology Informatics Market by Country, 2019 and 2030, % of Revenue 132
Figure 75. Contribution to MEA 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 133
Figure 76. Oncology Informatics Market in UAE, 2019-2030, $ mn 134
Figure 77. Oncology Informatics Market in Saudi Arabia, 2019-2030, $ mn 136
Figure 78. Oncology Informatics Market in South Africa, 2019-2030, $ mn 138
Figure 79. Growth Stage of Global Oncology Informatics Industry over the Forecast Period 141

Table 1. Snapshot of Global Oncology Informatics Market, 2019-2030 19
Table 2. Main Product Trends and Market Opportunities in Global Oncology Informatics Market 30
Table 3. Global Oncology Informatics Market by Product Type, 2019-2030, $ mn 38
Table 4. Key Products and EHR Vendors 41
Table 5. Key Products and PHM Vendors 43
Table 6. Key Products and CDSS Vendors 45
Table 7. Key Products and DDDI Vendors 47
Table 8. Global Oncology Informatics Market by Cancer Type, 2019-2030, $ mn 51
Table 9. Global Oncology Informatics Market by Application, 2019-2030, $ mn 57
Table 10. Global Oncology Informatics Market by End User, 2019-2030, $ mn 63
Table 11. Global Oncology Informatics Market by Region, 2019-2030, $ mn 71
Table 12. Leading National Oncology Informatics Market, 2019 and 2030, $ mn 73
Table 13. North America Oncology Informatics Market by Country, 2019-2030, $ mn 76
Table 14. U.S. Oncology Informatics Market by Product Type, 2019-2030, $ mn 80
Table 15. U.S. Oncology Informatics Market by Cancer Type, 2019-2030, $ mn 80
Table 16. U.S. Oncology Informatics Market by End User, 2019-2030, $ mn 80
Table 17. Canada Oncology Informatics Market by Product Type, 2019-2030, $ mn 83
Table 18. Canada Oncology Informatics Market by Cancer Type, 2019-2030, $ mn 83
Table 19. Canada Oncology Informatics Market by End User, 2019-2030, $ mn 83
Table 20. Mexico Oncology Informatics Market by Product Type, 2019-2030, $ mn 85
Table 21. Mexico Oncology Informatics Market by Cancer Type, 2019-2030, $ mn 85
Table 22. Mexico Oncology Informatics Market by End User, 2019-2030, $ mn 85
Table 23. Europe Oncology Informatics Market by Country, 2019-2030, $ mn 89
Table 24. Germany Oncology Informatics Market by Product Type, 2019-2030, $ mn 91
Table 25. Germany Oncology Informatics Market by Cancer Type, 2019-2030, $ mn 91
Table 26. Germany Oncology Informatics Market by End User, 2019-2030, $ mn 91
Table 27. UK Oncology Informatics Market by Product Type, 2019-2030, $ mn 93
Table 28. UK Oncology Informatics Market by Cancer Type, 2019-2030, $ mn 93
Table 29. UK Oncology Informatics Market by End User, 2019-2030, $ mn 93
Table 30. France Oncology Informatics Market by Product Type, 2019-2030, $ mn 95
Table 31. France Oncology Informatics Market by Cancer Type, 2019-2030, $ mn 95
Table 32. France Oncology Informatics Market by End User, 2019-2030, $ mn 95
Table 33. Spain Oncology Informatics Market by Product Type, 2019-2030, $ mn 97
Table 34. Spain Oncology Informatics Market by Cancer Type, 2019-2030, $ mn 97
Table 35. Spain Oncology Informatics Market by End User, 2019-2030, $ mn 97
Table 36. Italy Oncology Informatics Market by Product Type, 2019-2030, $ mn 99
Table 37. Italy Oncology Informatics Market by Cancer Type, 2019-2030, $ mn 99
Table 38. Italy Oncology Informatics Market by End User, 2019-2030, $ mn 99
Table 39. Russia Oncology Informatics Market by Product Type, 2019-2030, $ mn 101
Table 40. Russia Oncology Informatics Market by Cancer Type, 2019-2030, $ mn 101
Table 41. Russia Oncology Informatics Market by End User, 2019-2030, $ mn 101
Table 42. Oncology Informatics Market in Rest of Europe by Country, 2019-2030, $ mn 103
Table 43. APAC Oncology Informatics Market by Country, 2019-2030, $ mn 106
Table 44. Japan Oncology Informatics Market by Product Type, 2019-2030, $ mn 110
Table 45. Japan Oncology Informatics Market by Cancer Type, 2019-2030, $ mn 110
Table 46. Japan Oncology Informatics Market by End User, 2019-2030, $ mn 110
Table 47. China Oncology Informatics Market by Product Type, 2019-2030, $ mn 112
Table 48. China Oncology Informatics Market by Cancer Type, 2019-2030, $ mn 112
Table 49. China Oncology Informatics Market by End User, 2019-2030, $ mn 112
Table 50. Australia Oncology Informatics Market by Product Type, 2019-2030, $ mn 114
Table 51. Australia Oncology Informatics Market by Cancer Type, 2019-2030, $ mn 114
Table 52. Australia Oncology Informatics Market by End User, 2019-2030, $ mn 114
Table 53. India Oncology Informatics Market by Product Type, 2019-2030, $ mn 116
Table 54. India Oncology Informatics Market by Cancer Type, 2019-2030, $ mn 116
Table 55. India Oncology Informatics Market by End User, 2019-2030, $ mn 116
Table 56. South Korea Oncology Informatics Market by Product Type, 2019-2030, $ mn 118
Table 57. South Korea Oncology Informatics Market by Cancer Type, 2019-2030, $ mn 118
Table 58. South Korea Oncology Informatics Market by End User, 2019-2030, $ mn 118
Table 59. Oncology Informatics Market in Rest of APAC by Country, 2019-2030, $ mn 120
Table 60. South America Oncology Informatics Market by Country, 2019-2030, $ mn 123
Table 61. Argentina Oncology Informatics Market by Product Type, 2019-2030, $ mn 125
Table 62. Argentina Oncology Informatics Market by Cancer Type, 2019-2030, $ mn 125
Table 63. Argentina Oncology Informatics Market by End User, 2019-2030, $ mn 125
Table 64. Brazil Oncology Informatics Market by Product Type, 2019-2030, $ mn 127
Table 65. Brazil Oncology Informatics Market by Cancer Type, 2019-2030, $ mn 127
Table 66. Brazil Oncology Informatics Market by End User, 2019-2030, $ mn 127
Table 67. Chile Oncology Informatics Market by Product Type, 2019-2030, $ mn 129
Table 68. Chile Oncology Informatics Market by Cancer Type, 2019-2030, $ mn 129
Table 69. Chile Oncology Informatics Market by End User, 2019-2030, $ mn 129
Table 70. MEA Oncology Informatics Market by Country, 2019-2030, $ mn 133
Table 71. UAE Oncology Informatics Market by Product Type, 2019-2030, $ mn 135
Table 72. UAE Oncology Informatics Market by Cancer Type, 2019-2030, $ mn 135
Table 73. UAE Oncology Informatics Market by End User, 2019-2030, $ mn 135
Table 74. Saudi Arabia Oncology Informatics Market by Product Type, 2019-2030, $ mn 137
Table 75. Saudi Arabia Oncology Informatics Market by Cancer Type, 2019-2030, $ mn 137
Table 76. Saudi Arabia Oncology Informatics Market by End User, 2019-2030, $ mn 137
Table 77. South Africa Oncology Informatics Market by Product Type, 2019-2030, $ mn 139
Table 78. South Africa Oncology Informatics Market by Cancer Type, 2019-2030, $ mn 139
Table 79. South Africa Oncology Informatics Market by End User, 2019-2030, $ mn 139
Table 80. Breakdown of Global Market by Key Vendor, 2019, % 143
Table 81. Cerner Corporation: Company Snapshot 146
Table 82. Cerner Corporation: Business Segmentation 146
Table 83. Cerner Corporation: Product Portfolio 147
Table 84. Cerner Corporation: Revenue, 2016-2018, $ mn 147
Table 85. Cerner Corporation: Recent Developments 147
Table 86. Risk Evaluation for Investing in Global Market, 2019-2030 165
Table 87. Critical Success Factors and Key Takeaways 168

Interested in this report?
Get your FREE sample!

Safe and Secure SSl Encryption

Licensing options

3400
USD

Single User License
Site License
Global User License

How client has rates us?

Requirement Gathering & Methodology

Data Collection Techniques

Our Research Team & Data Sourcing

Data Science & Analytical Tools

Data Visualization & Presentation Skills

Project/ Report Delivery & After Sales Services

Testimonial

READY TO MIX MARKET HAS HELPED US TO UNDERSTAND PRODUCT, PRICE & VARIENTS OF ALL THE COMPETITION INCLUDING SMALL STARTUPS/REGIONAL PLAYERS.

PRODUCT DEVELOPMENT MANAGER

CEO

Vivek Arora

BEING A STARTUP WE WERE NOT AWARE ABOUT E-COMMERCE LOGISTICS, THE REPORT HAS RESOLVED ALL OUR QUERIES. THE TEAM HAVE IN DEPTH KNOWLEDGE OF LOGISTICS. REMARKABLE!!

EXECUTIVE DIRECTOR

Rahul Roy

THE REPORT WAS GOOD FOR OUR STUDY, I WOULD STRONGLY RECOMMEND BONAFIDE RESEARCH. A VERY CUSTOMER CENTRIC AND APPROACHABLE TEAM.

SALES DIRECTOR

Arjun Prasad

THE COMPANY WHICH THOROUGHLY UNDERSTANDS INDIAN CONSUMER AND INDIAN MARKET. WE ARE REALLY HAPPY TO WORK WITH BONAFIDE RESEARCH

MARKETING MANAGER

President

Manish Verma

Bonafide Research did an outstanding work on Global Hand Sanitizer project. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

MARKETING DIRECTOR

Gautam Saxena

The study done by Bonafide Research was customized with all our needs. We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done.

PRODUCT MANAGER

Tom Stone

I’m glad I decided to work with you. Thankful to the team for the amazing coordination, it was indeed a good experience, would definitely recommend and come back for future prospects.

Associate Director

Mark Wood

Global Oncology Informatics Market 2020-2030

Global Oncology Informatics Market 2020-2030